SCHEMBL6599478

SCHEMBL6599478

c1ccc2c(c1)CCCC2C1CCCC[N]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.43
IDO1 P14902 2/20 0.42
ADRA2A P08913 4/20 0.42
ADRA1A P35348 4/20 0.42
CYP2D6 P10635 2/20 0.42
LMNA P02545 1/20 0.42
HTR1A P08908 1/20 0.42
OPRM1 P35372 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
ADRA1D P25100 1/20 0.39
ADRA1B P35368 1/20 0.39
EPHX1 P07099 1/20 0.38
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899578 0.95 IDO1 (0.44) SIGMAR1IDO1ADRA2AADRA1ACYP2D6
SCHEMBL104670 0.87 SIGMAR1 (0.40) SIGMAR1IDO1ADRA2AADRA1ACYP2D6
SCHEMBL2202769 0.79 ADRA2A (0.45) SIGMAR1IDO1ADRA2AADRA1ACYP2D6
SCHEMBL145977 0.78 IDO1 (0.57) SIGMAR1IDO1ADRA2AADRA1ACYP2D6
SCHEMBL29357487 0.78 IDO1 (0.57) SIGMAR1IDO1ADRA2AADRA1ACYP2D6
SCHEMBL1206327 0.78 HTR2A (0.39) ADRA2AADRA1ACYP2D6HTR1AOPRM1
SCHEMBL10785005 0.75 SIGMAR1 (0.60) SIGMAR1IDO1
SCHEMBL6784204 0.75 IDO1 (0.53) SIGMAR1IDO1
SCHEMBL4661810 0.74 SIGMAR1 (0.63) SIGMAR1IDO1EPHX1
SCHEMBL21924071 0.74 SIGMAR1 (0.63) SIGMAR1IDO1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436266-A4 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS INC (US) 2004-12-22 EP disclosed
WO-2004026844-A9 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS INC (US) 2004-11-11 WO disclosed
EP-1436266-A2 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS Reddy US Therapeutics, Inc. (US) 2004-07-14 EP disclosed
WO-2003024926-A2 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS, INC. (US) 2003-03-27 WO disclosed